Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Equity (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Return on Equity data on record, last reported at 0.25% in Q3 2025.

  • For Q3 2025, Return on Equity fell 24.0% year-over-year to 0.25%; the TTM value through Sep 2025 reached 0.25%, down 24.0%, while the annual FY2024 figure was 0.44%, 5.0% up from the prior year.
  • Return on Equity reached 0.25% in Q3 2025 per COLL's latest filing, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.56% in Q2 2024 and bottomed at 0.22% in Q3 2022.
  • Average Return on Equity over 5 years is 0.21%, with a median of 0.24% recorded in 2021.
  • Peak YoY movement for Return on Equity: tumbled -68bps in 2022, then skyrocketed 72bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.32% in 2021, then crashed by -140bps to 0.13% in 2022, then surged by 364bps to 0.34% in 2023, then increased by 0bps to 0.34% in 2024, then fell by -25bps to 0.25% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.25% in Q3 2025, 0.18% in Q2 2025, and 0.19% in Q1 2025.